Results 211 to 220 of about 125,522 (281)

Decision letter: FBXL19 recruits CDK-Mediator to CpG islands of developmental genes priming them for activation during lineage commitment

, 2018

openalex   +1 more source

Pandering to Persuade [PDF]

Navin Kartik, Wouter Dessein, Yeon-Koo Che   +2 more
core  

Cell Cycle Plasticity and Heterogeneity: An Underappreciated Feature of Cancer and Treatment Response. [PDF]

Cancer Heterog Plast
Knudsen ES, O'Connor TN, Witkiewicz AK.
europepmc   +1 more source

Extending Chemoinformatics Techniques With JMolecular Energy: A Robust CDK‐Based Force Field Library [PDF]

Rami M. Abdallah
openalex   +1 more source

A paradigm shift for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer: a review of CDK inhibitors [PDF]

, 2018
Mariane Teodoro Fernandes, Jacob J. Adashek, Carmélia Maria Noia Barreto, Ana Cláudia Barbin Spinosa, Bárbara de Souza Gutierres, Gilberto Lopes, Auro del Giglio, Pedro Nazareth Aguiar   +7 more
openalex   +1 more source

Real-world evidence of ribociclib-induced hepatotoxicity in patients with breast cancer: a multi-center experience. [PDF]

BMC Cancer
Baş O, İnci BK, Eroğlu İ, Efil SC, Kaya S, Tolunay PK, Şahin TK, Karaçin C, Yazıcı O, Şendur MAN, Öksüzoğlu BÖÇ, Aksoy S.   +11 more
europepmc   +1 more source

[Expression of Concern]  CDKN2A (p16INK4A) affects the anti‑tumor effect of CDK inhibitor in somatotroph adenomas. [PDF]

Int J Mol Med
Chen Y, Li Z, Fang Q, Wang H, Li C, Gao H, Zhang Y.   +6 more
europepmc   +1 more source

PIK75 effectively reverses PI3K‒AKT activation caused by palbociclib resistance and synergistically inhibits the progression of esophageal squamous cell carcinoma. [PDF]

Sci Rep
Zhao Y, Li L, Jiang Y, Sun Y, Xu Y, Ye X, Zhang F, Zhu F, Pan Y, Ma S.   +9 more
europepmc   +1 more source

Supplementary Figure 2 from ¹⁸F-FLT PET, a Noninvasive Pharmacodynamic Biomarker of Tumor Cell Proliferation, Detected Differential Response to Various Cyclin-Dependent Kinase (CDK) Inhibitors

Anand Giddabasappa, Ziyue Karen Jiang, Bing Yang, Laigao Chen, Feng Liu, Edward Cabral, Sripad Ram, Britton Boras, Nanni Huser, Cathy C. Zhang, Kavon Noorbehesht, Lisa K. Manzuk, Ravi Visswanathan, Sepideh Mojtahedzadeh, Timothy Affolter, Jason Carmody, Aubrey Nayeon Kang, Matthew D. Petroski, Penny Lai Khamphavong, Todd VanArsdale, Quang‐Dé Nguyen, Kevin Maresca, Stephen G. Dann   +22 more
openalex   +1 more source

Comprehensive Survey of CDK Inhibitor Selectivity in Live Cells with Energy Transfer Probes

, 2019
Carrow I. Wells, Jim Vasta, Cesear Corona, Jennifer Wilkinson, Chad Zimprich, Morgan R. Ingold, Julie E. Pickett, David H. Drewry, Kathryn Pugh, K. Huber, Mei Cong, Poncho Meisenheimer, Timothy M. Willson, Matthew B. Robers   +13 more
openalex   +1 more source